If you live with chronic pain, you might have heard of spinal cord stimulation (SCS). It's a treatment that uses a device to send mild electrical pulses to your spinal cord, which can help block pain signals. But a new review of 187 studies shows that research on SCS isn't the same everywhere. It varies by region, and that could matter for your care.
The review looked at studies from around the world, focusing on adults with chronic pain lasting at least three months. It found that the average age of patients in studies differed by region. In Asian studies, patients tended to be older than those in North American studies. In European studies, patients were younger on average. This suggests that SCS might be studied in different age groups depending on where you live.
The review also found that most of the research, 57%, was funded by industry. That's a lot. And there was a link between where a study came from and who funded it. That could influence what gets studied and how results are interpreted.
One more thing: the most common pain condition studied globally was post-surgical pain syndrome in the thoracolumbar area, which is the middle and lower back. It made up 44.9% of the studies. So if you have that kind of pain, there's more research to guide your treatment. But if you have a different type of chronic pain, the evidence might be thinner.
This review is a big picture look, not a new experiment. It tells us where research stands, but it doesn't prove which treatment works best. And it doesn't tell us about side effects or long-term outcomes. Still, it highlights gaps in research that could affect how well SCS works for people in different regions and age groups. If you're considering SCS, talk to your doctor about whether the evidence applies to you.
